Zinc Therapy in HIV Infected Individuals Who Abuse Drugs

Completed · Not applicable · Has a placebo group

Conditions studied: HIV Infections, Substance-Related Disorders

In brief

Zinc deficiency is prevalent in HIV infected individuals who abuse drugs. The purpose of this study is to determine if zinc therapy will prevent immune failure in HIV infected individuals who abuse drugs and have low plasma zinc levels.

Key facts

Study ID

NCT00149552

Run by

Florida International University

People needed

231

Starts

2001-06-01

Expected to finish

2007-01-01

Last updated by the study team

2012-03-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV infected
• Drug User
• Blood zinc level greater than 0.35 mcg/mL and less than 0.75mcg/ml

You may not qualify if…

• Currently participating in an another clinical trial
• Blood selenium level less than 85 mcg/L
• Pregnant or intends to become pregnant

Where it is running

• Camillus House — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.